objectives: the aim of this research was the development of 111in-labeled porphyrins as possible radiopharmaceuticals for the imaging of tumors. methods: ligands, 5, 10, 15, 20-tetrakis (3, 5-dihydroxyphenyl) porphyrin) (tdhpp), 5, 10, 15, 20-tetrakis (4-hydroxyphenyl) porphyrin (thpp) and 5, 10, 15, 20-tetrakis (3,4-dimethoxyphenyl) porphyrin) (tdmpp) were labeled with 111incl3 (produced from ...